Clinical Trials

New Search
Title   Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
Disease/Condition   Kidney Diseases (incl Chronic Kidney Disease),Nephrology,Urologic Diseases
Eligibility Criteria   Click here for eligibility requirements
Principal Investigator   Enver Akalin, MD
Contact Name   Omar Mohammed
Contact Email
IRB/Protocol Number   16-02-386-01
Status   Active/Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No
Sub-Specialty   Transplant Surgery - Kidney